Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

Delayed Data
As of Feb 23
 +2.49 / +4.18%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 18 analysts offering 12-month price forecasts for Intercept Pharmaceuticals Inc have a median target of 107.50, with a high estimate of 253.00 and a low estimate of 50.00. The median estimate represents a +73.28% increase from the last price of 62.04.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Buy stock in Intercept Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -20.43%
Growthannually 14.49%


Growthquarterly -0.68%
Growthannually 48.90%
Key to the earnings and sales forecast charts.